[HTML][HTML] Prospective of 68Ga-radiopharmaceutical development
I Velikyan - Theranostics, 2014 - ncbi.nlm.nih.gov
Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …
has become an established method for medical research and clinical routine diagnostics on …
Cold Kit Labeling: The Future of 68Ga Radiopharmaceuticals?
N Lepareur - Frontiers in Medicine, 2022 - frontiersin.org
Over the last couple of decades, gallium-68 (68Ga) has gained a formidable interest for PET
molecular imaging of various conditions, from cancer to infection, through cardiac …
molecular imaging of various conditions, from cancer to infection, through cardiac …
Bifunctional gallium-68 chelators: Past, present, and future
P Spang, C Herrmann, F Roesch - Seminars in nuclear medicine, 2016 - Elsevier
This article reviews the development of bifunctional chelates for synthesising 68 Ga
radiopharmaceuticals. It structures the chelates into groups of macrocycles …
radiopharmaceuticals. It structures the chelates into groups of macrocycles …
Efficient bifunctional gallium-68 chelators for positron emission tomography: tris (hydroxypyridinone) ligands
DJ Berry, Y Ma, JR Ballinger, R Tavaré… - Chemical …, 2011 - pubs.rsc.org
Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone)
ligands - Chemical Communications (RSC Publishing) DOI:10.1039/C1CC12123E Royal …
ligands - Chemical Communications (RSC Publishing) DOI:10.1039/C1CC12123E Royal …
Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography
MD Bartholomä - Inorganica Chimica Acta, 2012 - Elsevier
In recent years, Positron Emission Tomography (PET) has become a practical, high
performance clinical imaging modality for visualization of biological process within the living …
performance clinical imaging modality for visualization of biological process within the living …
Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs
MA Santos, SM Marques, S Chaves - Coordination Chemistry Reviews, 2012 - Elsevier
Hydroxypyridinones (HPs) are a family of N-heterocyclic core chelators which, based on
their specific metal-coordination, easy manipulation/derivatization and biocompatibility, have …
their specific metal-coordination, easy manipulation/derivatization and biocompatibility, have …
Tripodal tris (hydroxypyridinone) ligands for immunoconjugate PET imaging with 89 Zr 4+: comparison with desferrioxamine-B
MT Ma, LK Meszaros, BM Paterson, DJ Berry… - Dalton …, 2015 - pubs.rsc.org
Due to its long half-life (78 h) and decay properties (77% electron capture, 23% β+, Emax=
897 keV, Eav= 397 keV, Eγ= 909 keV, Iγ= 100%) 89Zr is an appealing radionuclide for …
897 keV, Eav= 397 keV, Eγ= 909 keV, Iγ= 100%) 89Zr is an appealing radionuclide for …
Synthesis and Characterization of 68Ga-Labeled Curcumin and Curcuminoid Complexes as Potential Radiotracers for Imaging of Cancer and Alzheimer's Disease
Curcumin (CUR) and curcuminoids complexes labeled with fluorine-18 or technetium-99m
have recently shown their potential as diagnostic tools for Alzheimer's disease. Gallium-68 is …
have recently shown their potential as diagnostic tools for Alzheimer's disease. Gallium-68 is …
Hydroxypyridinone chelators: from iron scavenging to radiopharmaceuticals for PET imaging with gallium-68
Derivatives of 3, 4-hydroxypyridinones have been extensively studied for in vivo Fe3+
sequestration. Deferiprone, a 1, 2-dimethyl-3, 4-hydroxypyridinone, is now routinely used for …
sequestration. Deferiprone, a 1, 2-dimethyl-3, 4-hydroxypyridinone, is now routinely used for …
Hydroxypyridinone derivatives: a fascinating class of chelators with therapeutic applications-an update
S Chaves, L Piemontese, A Hiremathad… - Current Medicinal …, 2018 - ingentaconnect.com
Hydroxypyridinones (HPs) are a family of N-heterocyclic metal chelators, which have been
an attractive target in the development of a variety of new pharmaceutical drugs, due to their …
an attractive target in the development of a variety of new pharmaceutical drugs, due to their …